123 related articles for article (PubMed ID: 38367548)
21. The WD repeat-containing protein 5 (WDR5) antagonist WDR5-0103 restores the efficacy of cytotoxic drugs in multidrug-resistant cancer cells overexpressing ABCB1 or ABCG2.
Wu CP; Hsieh YJ; Tseng HY; Huang YH; Li YQ; Hung TH; Wang SP; Wu YS
Biomed Pharmacother; 2022 Oct; 154():113663. PubMed ID: 36081287
[TBL] [Abstract][Full Text] [Related]
22. Essential oils from Inula japonica and Angelicae dahuricae enhance sensitivity of MCF-7/ADR breast cancer cells to doxorubicin via multiple mechanisms.
Wu M; Li T; Chen L; Peng S; Liao W; Bai R; Zhao X; Yang H; Wu C; Zeng H; Liu Y
J Ethnopharmacol; 2016 Mar; 180():18-27. PubMed ID: 26795076
[TBL] [Abstract][Full Text] [Related]
23. Dacomitinib antagonizes multidrug resistance (MDR) in cancer cells by inhibiting the efflux activity of ABCB1 and ABCG2 transporters.
Fan YF; Zhang W; Zeng L; Lei ZN; Cai CY; Gupta P; Yang DH; Cui Q; Qin ZD; Chen ZS; Trombetta LD
Cancer Lett; 2018 May; 421():186-198. PubMed ID: 29331420
[TBL] [Abstract][Full Text] [Related]
24. The phenothiazine, trifluoperazine, is selectively lethal to ABCB1-expressing multidrug resistant cells.
Limniatis G; Georges E
Biochem Biophys Res Commun; 2021 Sep; 570():148-153. PubMed ID: 34284140
[TBL] [Abstract][Full Text] [Related]
25. Poziotinib Inhibits the Efflux Activity of the ABCB1 and ABCG2 Transporters and the Expression of the ABCG2 Transporter Protein in Multidrug Resistant Colon Cancer Cells.
Zhang Y; Wu ZX; Yang Y; Wang JQ; Li J; Sun Z; Teng QX; Ashby CR; Yang DH
Cancers (Basel); 2020 Nov; 12(11):. PubMed ID: 33158067
[TBL] [Abstract][Full Text] [Related]
26. Wallichinine reverses ABCB1-mediated cancer multidrug resistance.
Lv M; Qiu JG; Zhang WJ; Jiang QW; Qin WM; Yang Y; Zheng DW; Chen Y; Huang JR; Wang K; Wei MN; Cheng KJ; Shi Z
Am J Transl Res; 2016; 8(7):2969-80. PubMed ID: 27508017
[TBL] [Abstract][Full Text] [Related]
27. Crizotinib (PF-02341066) reverses multidrug resistance in cancer cells by inhibiting the function of P-glycoprotein.
Zhou WJ; Zhang X; Cheng C; Wang F; Wang XK; Liang YJ; To KK; Zhou W; Huang HB; Fu LW
Br J Pharmacol; 2012 Jul; 166(5):1669-83. PubMed ID: 22233293
[TBL] [Abstract][Full Text] [Related]
28. Erdafitinib Antagonizes ABCB1-Mediated Multidrug Resistance in Cancer Cells.
Feng W; Zhang M; Wu ZX; Wang JQ; Dong XD; Yang Y; Teng QX; Chen XY; Cui Q; Yang DH
Front Oncol; 2020; 10():955. PubMed ID: 32670878
[TBL] [Abstract][Full Text] [Related]
29. CEP-33779 antagonizes ATP-binding cassette subfamily B member 1 mediated multidrug resistance by inhibiting its transport function.
Tang SJ; Chen LK; Wang F; Zhang YK; Huang ZC; To KK; Wang XK; Talele TT; Chen ZS; Chen WQ; Fu LW
Biochem Pharmacol; 2014 Sep; 91(2):144-56. PubMed ID: 25058526
[TBL] [Abstract][Full Text] [Related]
30. Infigratinib (BGJ 398), a Pan-FGFR Inhibitor, Targets P-Glycoprotein and Increases Chemotherapeutic-Induced Mortality of Multidrug-Resistant Tumor Cells.
Boichuk S; Dunaev P; Mustafin I; Mani S; Syuzov K; Valeeva E; Bikinieva F; Galembikova A
Biomedicines; 2022 Mar; 10(3):. PubMed ID: 35327403
[TBL] [Abstract][Full Text] [Related]
31. Isopetasin and S-isopetasin as novel P-glycoprotein inhibitors against multidrug-resistant cancer cells.
Abdelfatah S; Böckers M; Asensio M; Kadioglu O; Klinger A; Fleischer E; Efferth T
Phytomedicine; 2021 Jun; 86():153196. PubMed ID: 32229058
[TBL] [Abstract][Full Text] [Related]
32. L-type calcium channel blockers reverse docetaxel and vincristine-induced multidrug resistance independent of ABCB1 expression in human lung cancer cell lines.
Chiu LY; Ko JL; Lee YJ; Yang TY; Tee YT; Sheu GT
Toxicol Lett; 2010 Feb; 192(3):408-18. PubMed ID: 19944135
[TBL] [Abstract][Full Text] [Related]
33. The SMAC mimetic LCL161 is a direct ABCB1/MDR1-ATPase activity modulator and BIRC5/Survivin expression down-regulator in cancer cells.
Chang YC; Kondapuram SK; Yang TH; Syed SB; Cheng SM; Lin TY; Lin YC; Coumar MS; Chang JY; Leung E; Cheung CHA
Toxicol Appl Pharmacol; 2020 Aug; 401():115080. PubMed ID: 32497533
[TBL] [Abstract][Full Text] [Related]
34. Chemosensitization by diverging modulation by short-term and long-term TNF-α action on ABCB1 expression and NF-κB signaling in colon cancer.
Walther W; Kobelt D; Bauer L; Aumann J; Stein U
Int J Oncol; 2015 Dec; 47(6):2276-85. PubMed ID: 26463665
[TBL] [Abstract][Full Text] [Related]
35. Wnt pathway activation and ABCB1 expression account for attenuation of proteasome inhibitor-mediated apoptosis in multidrug-resistant cancer cells.
Chong KY; Hsu CJ; Hung TH; Hu HS; Huang TT; Wang TH; Wang C; Chen CM; Choo KB; Tseng CP
Cancer Biol Ther; 2015; 16(1):149-59. PubMed ID: 25590413
[TBL] [Abstract][Full Text] [Related]
36. Bipiperidinyl derivatives of 23-hydroxybetulinic acid reverse resistance of HepG2/ADM and MCF-7/ADR cells.
Zhang DM; Li YJ; Shu C; Ruan ZX; Chen WM; Yiu A; Peng YH; Wang J; Lan P; Yao Z; Fung KP; Fu LW; Chen ZS; Ye WC
Anticancer Drugs; 2013 Jun; 24(5):441-54. PubMed ID: 23466650
[TBL] [Abstract][Full Text] [Related]
37. Novel Potent ABCB1 Modulator, Phenethylisoquinoline Alkaloid, Reverses Multidrug Resistance in Cancer Cell.
Sugisawa N; Ohnuma S; Ueda H; Murakami M; Sugiyama K; Ohsawa K; Kano K; Tokuyama H; Doi T; Aoki J; Ishida M; Kudoh K; Naitoh T; Ambudkar SV; Unno M
Mol Pharm; 2018 Sep; 15(9):4021-4030. PubMed ID: 30052463
[TBL] [Abstract][Full Text] [Related]
38. Gibberellin derivative GA-13315 sensitizes multidrug-resistant cancer cells by antagonizing ABCB1 while agonizes ABCC1.
Mo J; Kang M; Ye JX; Chen JB; Zhang HB; Qing C
Cancer Chemother Pharmacol; 2016 Jul; 78(1):51-61. PubMed ID: 27160689
[TBL] [Abstract][Full Text] [Related]
39. A dual PI3 kinase/mTOR inhibitor BEZ235 reverses doxorubicin resistance in ABCB1 overexpressing ovarian and pancreatic cancer cell lines.
Durrant DE; Das A; Dyer S; Kukreja RC
Biochim Biophys Acta Gen Subj; 2020 Jun; 1864(6):129556. PubMed ID: 32061787
[TBL] [Abstract][Full Text] [Related]
40. Apatinib (YN968D1) reverses multidrug resistance by inhibiting the efflux function of multiple ATP-binding cassette transporters.
Mi YJ; Liang YJ; Huang HB; Zhao HY; Wu CP; Wang F; Tao LY; Zhang CZ; Dai CL; Tiwari AK; Ma XX; To KK; Ambudkar SV; Chen ZS; Fu LW
Cancer Res; 2010 Oct; 70(20):7981-91. PubMed ID: 20876799
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
